A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss
Obesity2018Vol. 27(2), pp. 205–216
Citations Over TimeTop 10% of 2018 papers
Frank L. Greenway, Louis J. Aronne, Anne Raben, Arne Astrup, Caroline M. Apovian, James O. Hill, Lee M. Kaplan, Ken Fujioka, Erika Matejkova, Š Svačina, Livio Luzi, Lucio Gnessi, Santiago Navas‐Carretero, J. Alfredo Martínéz, Christopher D. Still, Alessandro Sannino, Cosimo Saponaro, Christian Demitri, Lorien E. Urban, Harry Leider, Elaine Chiquette, Eyal Ron, Yishai Zohar, Hassan Heshmati
Abstract
Gelesis100 is a promising new nonsystemic therapy for overweight and obesity with a highly desirable safety and tolerability profile.
Related Papers
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)